Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
The expansion positions Cambrex with the largest and most advanced API facility in the United States
The plant is scheduled to come on stream in September 2024
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Subscribe To Our Newsletter & Stay Updated